Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole
Demographics (1)
- sex - Gender of participant (phv00222697.v1.p1)
Other (9)
- ANALYTE_TYPE - Analyte type (phv00222700.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00222692.v1.p1)
- SAMPID - Sample ID (phv00222694.v1.p1)
- SAMPID - De-identified sample ID (phv00222698.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00222699.v1.p1)
- SAMPLE_USE - Sample Use (phv00222695.v1.p1)
- SUBJID - Subject ID (phv00222693.v1.p1)
- SUBJID - Subject ID (phv00222691.v1.p1)
- SUBJID - De-identified Subject ID (phv00222696.v1.p1)